Skip to main content

Market Overview

Piper Jaffray Upgrades ICU Medical To Overweight


Analysts at Piper Jaffray upgraded ICU Medical (NASDAQ: ICUI) from Neutral to Overweight.

The price target for ICU Medical has been raised from $60.00 to $86.00.

ICU Medical shares have gained 15.67% over the past 52 weeks, while the S&P 500 index has surged 15.31% in the same period.

ICU Medical's shares rose 7.94% to $77.51 in pre-market trading.

Latest Ratings for ICUI

Feb 2021Raymond JamesMaintainsOutperform
Feb 2021Raymond JamesMaintainsOutperform
Jan 2021KeyBancMaintainsOverweight

View More Analyst Ratings for ICUI
View the Latest Analyst Ratings


Related Articles (ICUI)

View Comments and Join the Discussion!

Posted-In: Piper JaffrayUpgrades Analyst Ratings

Latest Ratings

VORStifelInitiates Coverage On58.0
VORGoldman SachsInitiates Coverage On19.0
TERNJP MorganInitiates Coverage On32.0
TERNCowen & Co.Initiates Coverage On
TERNGoldman SachsInitiates Coverage On29.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at